Protara Therapeutics, Inc.

NASDAQ:TARA

Biotechnology

Healthcare
$2.34 -1.27%

-$0.05 today

Market cap
$144.07M
Beta
1.45
P/E (TTM)
-2.7
EPS (TTM)
-$1.48
52W Low $2.77High $7.82

Volume 1.15M

Average 0.73M

TARA Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How TARA compares with its peers on the latest reported figures

TARA Competitors Peer median
Net Margin for TARA and competitors
Company Period LTM level YoY 3-year change
CDXSCodexis, Inc.LTM Mar 2026-41.0% +108.5 pp-38.2 pp
IVVDInvivyd, Inc.LTM Mar 2026-138.9% +250.1 pp—
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026-167.0% +2130.9 pp+793.9 pp
MDWDMediWound Ltd.LTM Mar 2026-180.3% -69.8 pp-66.8 pp
OABIOmniAb, Inc.LTM Mar 2026-187.7% +41.4 pp-309.2 pp
SGMOSangamo Therapeutics, Inc.LTM Mar 2026-356.9% -232.3 pp-138.1 pp
PRLDPrelude Therapeutics IncorporatedLTM Mar 2026-465.3% +1360.8 pp—
NTHINeonc Technologies Holdings, Inc.FY2025-155404.4% ——
TARAProtara Therapeutics, Inc.FY2025— ——
SLSSELLAS Life Sciences Group, Inc.FY2025— ——
Peer median (excluding TARA) -184.0%+108.5 pp-66.8 pp

Competitors are the stored peer set for TARA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00341K0362K
Gross Profit00(341K)0(362K)
Gross Margin—————
Research & Development21.09M16.81M24.79M31.7M42.63M
Selling, General & Admin26.4M20.74M18.62M17.45M21.92M
Operating Expenses47.49M67.06M43.27M49.15M64.19M
Depreciation & Amortization117K248K341K332K362K
EBITDA(45.4M)(64.57M)(40.08M)(44.26M)(57.08M)
EBITDA Margin—————
Operating Income(47.49M)(67.06M)(43.61M)(49.15M)(64.55M)
Operating Margin—————
Interest Income237K1.11M2.73M4.14M6.33M
Interest Expense1.74M1.14M000
Other Income / Expenses237K1.11M3.19M4.56M7.11M
Income Before Tax(47.25M)(65.95M)(40.42M)(44.6M)(57.44M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(47.25M)(65.95M)(40.42M)(44.6M)(57.44M)
Net Margin—————
EPS (Basic)(4.20)(5.86)(3.57)(2.17)(1.34)
EPS (Diluted)(4.20)(5.86)(3.57)(2.17)(1.34)
Weighted Avg Shares11.23M11.26M11.33M20.59M42.84M
Weighted Avg Shares (Diluted)11.23M11.26M11.33M20.59M42.84M

Protara Therapeutics, Inc.

NASDAQ:TARA

Intrinsic Alpha fair value

Locked

Current Price

$2.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.